How do I buy Sana Biotechnology, Inc. Common Stock (SANA) stock?

Buying Sana Biotechnology, Inc. Common Stock (SANA) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and verify your identity. Make a deposit. Search for the code "SANA", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy SANA by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

How do I tell if SANA is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Sana Biotechnology, Inc. Common Stock (SANA) Stock

Q: What is the minimum investment for SANA on Gotrade?

On Gotrade , you don't have to buy a full share. With fractional shares, you can start investing in Sana Biotechnology, Inc. Common Stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.

NASDAQ · SANA

Trade SANA

Key stats

Market cap: $686.16M
Price / Earnings ratio: -4.9x
EPS (TTM): -$0.53
Volume: Loading
52-week high: $5.49
52-week low: $2.22
EPS vs analyst estimate: +21.1%Q3 FY25 · -$0.15 vs -$0.19

Source: third-party data provider, as of November 13, 2026

EPS estimate: analyst consensus

Compare with SANA

Technical indicators

RSI 14: 39.76
MACD 12/26/9: -0.11
EMA 9 of MACD: -0.12
MACD histogram: 0.02
SMA 50: $2.79; Price below SMA 50
EMA 50: $2.74; Price below EMA 50
SMA 200: $3.30; Price below SMA 200
EMA 200: $3.32; Price below EMA 200

Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.

Analyst ratings

Analyst consensus: Buy

Based on 1 analyst rating

Strong Sell0

Sell0

Hold0

Buy1

Strong Buy0

Third-party analyst opinion, not a recommendation from Gotrade.

Financials

Performance

Revenue

Net income

Net margin %

2021

2022

2023

2024

2025

0000

Debt & Balance Sheet

Total assets

Total liabilities

2021

2022

2023

2024

2025

1B894M447M0

Revenue to Profit

2025

$0.0

Revenue

$0.0

Cost of revenue

$0.0

Gross profit

$0.0

Operating expenses

$-244.2M

Net income

Earnings

EPS forecast

Actual EPS

$-0.15

$-0.19

Q3FY25

$-0.13

Q4FY25

$-0.11

Q1FY26

$-0.12

Q2FY26

$-0.12

Q3FY26

The market is expecting earnings per share of -$0.12 for this quarter. The company has not yet shared when it is announcing earnings.

Source: third-party data provider

About Sana Biotechnology, Inc. Common Stock

Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.

SectorHealthcare

IndustryBiotechnology

Employees142

CEODr. Steven D. Harr M.D.

IPO DateFeb 3, 2021

HeadquartersSeattle, WA

Key Executives

Name	Title	Year Born
Dr. Steven D. Harr M.D.	President, CEO & Director	1970
Mr. Brian D. Piper M.B.A.	Executive VP & CFO	1972
Ms. Susan Wyrick	Treasurer, Principal Accounting Officer and Senior VP of Finance & Accounting	1973
Mr. Snehal Patel	Executive VP & Chief Technical Officer	—
Dr. Dhavalkumar D. Patel M.D., Ph.D.	Executive VP & Chief Scientific Officer	1961
Mr. Aaron M. Grossman	Executive VP, Chief Legal Officer & Corporate Secretary	1972
Ms. Debra Wisdom	VP & Head of People	—
Dr. Gary Meininger M.D.	Executive VP & Chief Medical Officer	—
Dr. Yuko Soneoka J.D., Ph.D.	SVP & Head of Intellectual Property	—
Mr. John Gerecitano M.D., Ph.D.	Senior Vice President, Clinical Lead, Hematology & Oncology Development	—

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021											-11.4	-12.1
2022	-43.8	-26.7	+37.0	-13.0	-34.4	+29.4	+2.6	+11.6	-11.2	-3.5	-14.3	-10.8
2023	+22.3	-22.1	-8.9	+64.3	+10.1	-2.3	-3.0	-6.6	-27.5	-17.3	+31.4	+1.0
2024	+30.7	+72.2	-11.3	-11.1	-22.1	-30.1	+11.3	+12.9	-25.7	-17.5	-24.0	-42.8
2025	+95.2	-14.7	-30.9	+26.7	+14.2	+24.1	+43.5	-21.7	+25.0	+33.8	-5.9	+1.8
2026	+5.7	-8.3	-30.6	+7.9	+0.9	+8.7	-12.1	+21.7	-23.8	-11.1	-4.6

Stocks in the same sector

Vertex Pharmaceuticals

ABEO

Abeona Therapeutics Inc.

FAQ

Buying Sana Biotechnology, Inc. Common Stock (SANA) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and verify your identity.
Make a deposit.
Search for the code "SANA", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy SANA by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full share. With fractional shares, you can start investing in Sana Biotechnology, Inc. Common Stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.

At the moment, Sana Biotechnology, Inc. Common Stock (SANA) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track SANA's performance via the price chart in the Gotrade app.

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place an order any time. It goes through when the US market (NYSE/NASDAQ) opens: 9:30 AM to 4:00 PM New York time, Monday to Friday. Pre-market and after-hours trading are open too.

The market is closed on US public holidays. The Gotrade app shows whether the market is open.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trade Faster. Easier. Smarter.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

Sana Biotechnology, Inc. Common Stock (SANA) Stock

Key stats

Compare with SANA

Recent news

Stocktwits Pharma Pulse: Lilly, Novo Lead A Busy Week — Here Are The Stocks And Readouts To Watch

Stocktwits Pharma Pulse: Lilly, Novo Lead A Busy Week — Here Are The Stocks And Readouts To Watch

3 Promising Genomics Stocks to Add to Your Portfolio in 2026

3 Promising Genomics Stocks to Add to Your Portfolio in 2026

Sana (SANA) Upgraded to Buy: Here's What You Should Know

Sana (SANA) Upgraded to Buy: Here's What You Should Know

SANA Stock Rallies 24% After Hours — How Much Is Mayo Clinic Investing In The Company?

SANA Stock Rallies 24% After Hours — How Much Is Mayo Clinic Investing In The Company?

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

Stocktwits Pharma Pulse: Lilly, Novo Lead A Busy Week — Here Are The Stocks And Readouts To Watch

Stocktwits Pharma Pulse: Lilly, Novo Lead A Busy Week — Here Are The Stocks And Readouts To Watch

3 Promising Genomics Stocks to Add to Your Portfolio in 2026

3 Promising Genomics Stocks to Add to Your Portfolio in 2026

Sana (SANA) Upgraded to Buy: Here's What You Should Know

Sana (SANA) Upgraded to Buy: Here's What You Should Know

SANA Stock Rallies 24% After Hours — How Much Is Mayo Clinic Investing In The Company?

SANA Stock Rallies 24% After Hours — How Much Is Mayo Clinic Investing In The Company?

Genomics Stocks That Deserve a Place in Your Portfolio in 2026

Genomics Stocks That Deserve a Place in Your Portfolio in 2026

Sana Biotechnology (SANA) Is Up 5.46% in One Week: What You Should Know

Sana Biotechnology (SANA) Is Up 5.46% in One Week: What You Should Know

Wall Street Analysts Think Sana (SANA) Could Surge 74.2%: Read This Before Placing a Bet

Wall Street Analysts Think Sana (SANA) Could Surge 74.2%: Read This Before Placing a Bet

Three Genomics Stocks Worth Tracking This Year

Three Genomics Stocks Worth Tracking This Year

Top 3 Genomics Stocks to Consider for Your Portfolio

Top 3 Genomics Stocks to Consider for Your Portfolio

All You Need to Know About Sana (SANA) Rating Upgrade to Buy

All You Need to Know About Sana (SANA) Rating Upgrade to Buy

About Sana Biotechnology, Inc. Common Stock

Key Executives

Fundamentals

Valuation

Profitability

Trading

Technical indicators

Analyst views

Seasonality

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trade Faster. Easier. Smarter.

#ReadyGoTrade